In addition, melanoma patients carrying MC1R variants as well as CDKN2A mutations, show clinically hypopigmented nevi and, at RCM, roundish cells infiltrating the dermo–epidermal junction [137]. This evidence concerns the gene CDKN2A and melanoma.